tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CTXR Stock Latest News

Citius Highlights Positive LYMPHIR Phase 1 Gynecologic Cancer Data
Company AnnouncementsCitius Highlights Positive LYMPHIR Phase 1 Gynecologic Cancer Data
13d ago
8K
CTXR
Citius Oncology Reports Positive LYMPHIR Phase 1 CAR-T Data
PremiumCompany Announcements
Citius Oncology Reports Positive LYMPHIR Phase 1 CAR-T Data
19d ago
8K
CTXR
Citius Pharmaceuticals receives $3.8M through NJEDA program
PremiumThe Fly
Citius Pharmaceuticals receives $3.8M through NJEDA program
27d ago
CTXR
Citius Pharmaceuticals Posts First Revenue Amid Listing Risk
PremiumCompany Announcements
Citius Pharmaceuticals Posts First Revenue Amid Listing Risk
1M ago
8K
CTXR
Citius Oncology reports Q1 EPS (6c) vs. (9c) last year
PremiumThe Fly
Citius Oncology reports Q1 EPS (6c) vs. (9c) last year
1M ago
CTOR
CTXR
Citius Pharmaceuticals reports $3.9M in revenue following launch of Lymphir
PremiumThe FlyCitius Pharmaceuticals reports $3.9M in revenue following launch of Lymphir
1M ago
CTOR
CTXR
Citius Pharmaceuticals reports Q1 EPS (41c) vs. ($1.30) last year
Premium
The Fly
Citius Pharmaceuticals reports Q1 EPS (41c) vs. ($1.30) last year
1M ago
CTOR
CTXR
Is CTXR a Buy, Before Earnings?
Premium
Pre-Earnings
Is CTXR a Buy, Before Earnings?
2M ago
CTXR
Citius Oncology to sell 1.28M shares at $1.09 in registered direct offering
PremiumThe Fly
Citius Oncology to sell 1.28M shares at $1.09 in registered direct offering
3M ago
CTOR
CTXR
Citius Pharmaceuticals Launches LYMPHIR for T-Cell Lymphoma
PremiumCompany Announcements
Citius Pharmaceuticals Launches LYMPHIR for T-Cell Lymphoma
4M ago
8K
CTXR
Citius Oncology to advance launch of Lymphir with Verix AI integration
PremiumThe Fly
Citius Oncology to advance launch of Lymphir with Verix AI integration
4M ago
CTOR
CTXR
Citius Pharmaceuticals Announces LYMPHIR Commercialization Plans
PremiumCompany Announcements
Citius Pharmaceuticals Announces LYMPHIR Commercialization Plans
5M ago
8K
CTXR
Citius Pharmaceuticals Secures $6M in Stock Offering
PremiumCompany AnnouncementsCitius Pharmaceuticals Secures $6M in Stock Offering
5M ago
8K
CTXR
Citius Pharmaceuticals announces $6M registered direct offering priced ATM
Premium
The Fly
Citius Pharmaceuticals announces $6M registered direct offering priced ATM
5M ago
CTXR
Citius Oncology announces distribution agreement with McKesson
Premium
The Fly
Citius Oncology announces distribution agreement with McKesson
5M ago
MCK
CTOR
Citius Oncology signs exclusive commercialization agreement with EVERSANA
PremiumThe Fly
Citius Oncology signs exclusive commercialization agreement with EVERSANA
5M ago
CTOR
CTXR
Citius Oncology announces pricing of $9M registered direct offering
PremiumThe Fly
Citius Oncology announces pricing of $9M registered direct offering
6M ago
CTOR
CTXR
Citius Pharma Reports Q2 2025 Financial Results
PremiumCompany Announcements
Citius Pharma Reports Q2 2025 Financial Results
7M ago
CTXR
Citius Pharmaceuticals reports Q3 EPS (8c) vs.(7c) last year
PremiumThe Fly
Citius Pharmaceuticals reports Q3 EPS (8c) vs.(7c) last year
7M ago
CTXR
Citius Oncology signs distribution agreement for Lymphir with Cencora
PremiumThe FlyCitius Oncology signs distribution agreement for Lymphir with Cencora
8M ago
CTOR
CTXR
Citius Pharmaceuticals Regains Nasdaq Compliance
Premium
Company Announcements
Citius Pharmaceuticals Regains Nasdaq Compliance
9M ago
8K
CTXR
Citius Oncology expects commercial launch of Lymphir in second half of 2025
Premium
The Fly
Citius Oncology expects commercial launch of Lymphir in second half of 2025
9M ago
CTOR
CTXR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >